Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

135,187 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Falchook GS, Peeters M, Rottey S, Dirix LY, Obermannova R, Cohen JE, Perets R, Frommer RS, Bauer TM, Wang JS, Carvajal RD, Sabari J, Chapman S, Zhang W, Calderon B, Peterson DA. Falchook GS, et al. Among authors: wang js. Invest New Drugs. 2021 Apr 14. doi: 10.1007/s10637-021-01088-4. Online ahead of print. Invest New Drugs. 2021. PMID: 33852104
Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.
Mast FD, Fridy PC, Ketaren NE, Wang J, Jacobs EY, Olivier JP, Sanyal T, Molloy KR, Schmidt F, Rutkowska M, Weisblum Y, Rich LM, Vanderwall ER, Dambrauskas N, Vigdorovich V, Keegan S, Jiler JB, Stein ME, Olinares PDB, Hatziioannou T, Sather DN, Debley JS, Fenyö D, Sali A, Bieniasz PD, Aitchison JD, Chait BT, Rout MP. Mast FD, et al. Among authors: wang j. bioRxiv. 2021 Apr 10:2021.04.08.438911. doi: 10.1101/2021.04.08.438911. Preprint. bioRxiv. 2021. PMID: 33851164 Free PMC article.
135,187 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page